The event unites senior executives from the generic and biosimilar industry to provide fresh insights future market trends, innovative commercial strategies and opportunities for growth for affordable medicines.
Through a mixture of plenary keynote sessions, roundtables, focused work streams, the event will address a comprehensive range of key topics, including:
Making medicines affordable
CEO Panel
Building scale and market share
Mature and emerging market review
Payers perspective and pricing trends
Biosimilar development challenges
Pharmacovogilance and post launch safety monitoring
Clinical development strategies
Developments in global intellectual property
Regulatory strategy for generics and biosimilars
How is the health policy landscape supporting affordable medicines?
How to develop an integrated approach to biosimilar development and commercialization
Through a mixture of plenary keynote sessions, roundtables, focused work streams, the event will address a comprehensive range of key topics, including:
Making medicines affordable
CEO Panel
Building scale and market share
Mature and emerging market review
Payers perspective and pricing trends
Biosimilar development challenges
Pharmacovogilance and post launch safety monitoring
Clinical development strategies
Developments in global intellectual property
Regulatory strategy for generics and biosimilars
How is the health policy landscape supporting affordable medicines?
How to develop an integrated approach to biosimilar development and commercialization
